Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FALS”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Not applicableWithdrawnNCT01459302
What this trial is testing

Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders

Who this might be right for
Amyotrophic Lateral SclerosisFrontotemporal DementiaPLS+7 more
University of Massachusetts, Worcester
Testing effectiveness (Phase 2)Study completedNCT01083667
What this trial is testing

SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Familial Amyotrophic Lateral Sclerosis
Weill Medical College of Cornell University 32
Not applicableStudy completedNCT03868345
What this trial is testing

Speech Analysis in ALS Patients

Who this might be right for
ALSAmyotrophic Lateral SclerosisLou Gehrig Disease
Barrow Neurological Institute 26
Large-scale testing (Phase 3)Ended earlyNCT01622088
What this trial is testing

Phase 3 Extension Study of Dexpramipexole in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 616
Not applicableActive Not RecruitingNCT07796776
What this trial is testing

The Aim of the Study is to Characterize Patients Exhibiting Muscular Atrophy and Weakness Who Require a Muscle Biopsy for Diagnosis (IBM vs Atypical MND), Through an Innovative Technique Which Enables the Evaluation of the Neuromuscular Junction Involvement in Each Condition

Who this might be right for
Inclusion Body Myositis (IBM)Motor Neuron Disease, Amyotrophic Lateral Sclerosis
IRCCS San Raffaele 30
Post-approval studies (Phase 4)Looking for participantsNCT05923905
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients

Who this might be right for
Sporadic and Familial Amyotrophic Lateral Sclerosis
Peking University Third Hospital 64
Testing effectiveness (Phase 2)Looking for participantsNCT07571486
What this trial is testing

Therapeutic Approach of Repeated Transient Blood-brain Barrier Opening in Amyotrophic Lateral Sclerosis.

Who this might be right for
Amyotrophic Lateral SclerosisCharcot Disease
Assistance Publique - Hôpitaux de Paris 23
Not applicableStudy completedNCT07170501
What this trial is testing

Postural Control as a Predictor of Disability, Fall-Related Fear, and Social Participation in Elderly Women With Non-Specific Low Back Pain

Who this might be right for
Low Back PainFALS
Cairo University 70
Testing effectiveness (Phase 2)Study completedNCT03204500
What this trial is testing

Dual Treatment With Lithium and Valproate in ALS.

Who this might be right for
Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis, Sporadic
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez 43
Testing effectiveness (Phase 2)Study completedNCT01849770
What this trial is testing

Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)

Who this might be right for
Sporadic Amyotrophic Lateral Sclerosis
University of Washington 75
Not applicableStudy completedNCT02414230
What this trial is testing

F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Tammie L. S. Benzinger, MD, PhD 9
Early research (Phase 1)WithdrawnNCT02242071
What this trial is testing

Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Neurogen Brain and Spine Institute
Large-scale testing (Phase 3)Study completedNCT00706147
What this trial is testing

Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Miami 38
Not applicableStudy completedNCT05852405
What this trial is testing

Clinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALS

Who this might be right for
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Ambulanzpartner Soziotechnologie APST GmbH 2,000
Early research (Phase 1)UnknownNCT00673140
What this trial is testing

Far Infrared Irradiation for Control, Management and Treatment of Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
GAAD Medical Research Institute Inc. 7
Not applicableStudy completedNCT02686268
What this trial is testing

Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS

Who this might be right for
C9ORF72 Amyotrophic Lateral Sclerosis (ALS)
Washington University School of Medicine 128
Early research (Phase 1)Looking for participantsNCT07401121
What this trial is testing

Safety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral Sclerosis

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Celosia Therapeutics Pty Ltd 15
Not applicableLooking for participantsNCT07533903
What this trial is testing

Functional Outcomes and Control Using Synchron BCI - Australia

Who this might be right for
Neurologic DisorderNeurologic DiseasesMND (Motor Neurone DIsease)+4 more
Synchron, Inc. 10
Not applicableUnknownNCT05725759
What this trial is testing

Rehabilitation in SOD1 ALS Treated With Tofersen

Who this might be right for
Amyotrophic Lateral SclerosisLou Gehrig DiseaseFamilial Amyotrophic Lateral Sclerosis+2 more
Washington University School of Medicine 10
Not applicableNo Longer AvailableNCT03537807
What this trial is testing

Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisALSLou Gehrig Disease+3 more
Biohaven Pharmaceuticals, Inc.
Next Page